Figures & data
Table 1 Characteristics of patients, tumor, complications, and treatment procedures
Table 2 General characteristics of subjects in the three groups
Figure 1 The Kaplan–Meier survival curves for patients with MHCCs: significantly better survival of MHCC patients undergoing treatment with TACE plus PMCT (solid line) compared to MHCC patients undergoing TACE treatment (dashed line) and palliative treatment (bold dashed line).
Abbreviations: cumul, cumulative; MHCC, massive hepatocellular carcinoma; PMCT, percutaneous microwave coagulation therapy; TACE, transcatheter arterial chemoembolization.
Figure 2 Correlation analysis of MHCC patients: MHCC patients with multiple TACE sessions had longer survival time than single TACE treatment.
Note: Statistical analysis was performed with Spearman’s correlation analysis. Abbreviations: MHCC, massive hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.
Table 3 Demographic and clinical characteristics of patients according to TACE sessions
Figure 3 The Kaplan–Meier survival curves for MHCC patients: significantly better survival of MHCC patients who received TACE treatments more than three times (solid line) compared to MHCC patients who received TACE treatments less than or equal to three times (dashed line).
Abbreviations: cumul, cumulative; MHCC, massive hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.
Table 4 Results of univariate and multivariate analyses in 102 HCC patients